Literature DB >> 9869997

Case report: inappropriate discharge of an implantable cardioverter-defibrillator caused by the combined count criterion.

C Wolpert1, W Jung, S Spehl, T Korte, B Lüderitz.   

Abstract

We describe a rare case of an inappropriate defibrillator discharge during a sinus tachycardia with single fast sensed beats fulfilling the ventricular fibrillation rate criterion, activating the "combined count criterion," although the prevalent sinus tachycardia was inside a ventricular tachycardia rate zone, programmed to monitor only mode. The "combined count criterion" is a safety feature that ensures defibrillation therapy in case of a tachyarrhythmia inside the ventricular tachycardia detection zone, that is temporarily crossing the ventricular fibrillation detection rate. This case reports shows that there is a low but unpredictable risk of device therapy even in a zone programmed to monitor only mode. This phenomenon should be considered when a monitor only zone is installed for revelation of slower tachyarrhythmias.

Entities:  

Mesh:

Year:  1998        PMID: 9869997     DOI: 10.1023/a:1009716907852

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  9 in total

1.  Survival of patients who have received appropriate shocks from their implantable defibrillators.

Authors:  R N Fogoros; J J Elson; C A Bonnet
Journal:  Pacing Clin Electrophysiol       Date:  1991-11       Impact factor: 1.976

2.  Long-term outcome with the automatic implantable cardioverter-defibrillator.

Authors:  R A Winkle; R H Mead; M A Ruder; V A Gaudiani; N A Smith; W S Buch; P Schmidt; T Shipman
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

3.  Pseudo-oversensing of the T wave by an implantable cardioverter defibrillator: a nonclinical problem.

Authors:  D W Frazier; M S Stanton
Journal:  Pacing Clin Electrophysiol       Date:  1994-07       Impact factor: 1.976

4.  Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Authors:  W Grimm; B F Flores; F E Marchlinski
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

5.  Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems.

Authors:  T Korte; W Jung; S Spehl; C Wolpert; R Moosdorf; M Manz; B Lüderitz
Journal:  Pacing Clin Electrophysiol       Date:  1995-11       Impact factor: 1.976

Review 6.  The proarrhythmic potential of implantable cardioverter-defibrillators.

Authors:  S L Pinski; G J Fahy
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

7.  Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy.

Authors:  B G Hook; F E Marchlinski
Journal:  J Am Coll Cardiol       Date:  1991-03-15       Impact factor: 24.094

8.  Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.

Authors:  D S Echt; K Armstrong; P Schmidt; P E Oyer; E B Stinson; R A Winkle
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

9.  Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis.

Authors:  B G Hook; D J Callans; R B Kleiman; B T Flores; F E Marchlinski
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

  9 in total
  2 in total

1.  Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment.

Authors:  L Lickfett; C Wolpert; W Jung; S Spehl; L Pizzulli; B Esmailzadeh; B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

2.  Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Authors:  Christian Veltmann; Juergen Kuschyk; Rainer Schimpf; Florian Streitner; Nina Schoene; Martin Borggrefe; Christian Wolpert
Journal:  Clin Res Cardiol       Date:  2009-09-16       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.